ICPT Shares Outstanding History



Below is a table of the ICPT shares outstanding history going back to 10/11/2012:

Date ICPT Shares Outstanding
10/11/201215.03M
11/12/201216.51M
3/15/201316.61M
5/1/201316.81M
8/1/201319.18M
10/31/201319.34M
2/28/201419.52M
4/15/201421.06M
4/30/201421.09M
7/31/201421.22M
10/31/201421.36M
2/15/201522.64M
4/15/201524.07M
4/30/201524.07M
7/15/201524.20M
10/31/201524.33M
1/31/201624.41M
4/15/201624.60M
7/31/201624.73M
10/31/201624.81M
1/31/201724.83M
4/28/201725.01M
6/30/201725.10M
9/30/201725.10M
12/31/201725.17M
3/31/201825.33M
6/30/201829.56M
9/30/201829.65M
12/31/201829.69M
3/31/201929.78M
6/30/201932.70M
8/6/201916.05M
9/30/201932.73M
12/31/201932.85M
3/31/202032.94M
6/30/202032.98M
9/30/202032.99M
12/31/202033.02M
3/31/202133.15M
6/30/202133.20M
9/30/202129.55M
1/31/202229.69M
3/31/202229.71M
6/30/202229.80M
9/30/202241.42M
1/31/202341.67M
3/31/202341.69M
11/2/202341.83M

Also see: ICPT Market Cap History
ICPT YTD Return
ICPT Historical Shares Outstanding:
+9.69% CAGR
ICPT Historical Shares Outstanding: +9.69% CAGR

Mouse over chart for data details
10/11/2012 ...11/2/2023
Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases utilizing its proprietary bile acid chemistry. Co.'s marketed product, Ocaliva® (obeticholic acid or OCA), is an farnesoid X receptor agonist approved in the U.S., the European Union and several other jurisdictions for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. In addition, Co. is developing OCA for additional indications, including nonalcoholic steatohepatitis. We show 48 historical shares outstanding datapoints in our coverage of ICPT's shares outstanding history.

Understanding the changing numbers of ICPT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ICPT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ICPT by allowing them to research ICPT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ICPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Intercept Pharmaceuticals (ICPT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ICUI Shares Outstanding History
ICVX Shares Outstanding History
IDRA Shares Outstanding History
IDXG Shares Outstanding History
IDXX Shares Outstanding History
IDYA Shares Outstanding History
IGAP Shares Outstanding History
IGMS Shares Outstanding History
IIN Shares Outstanding History
IKNA Shares Outstanding History
More Healthcare companies »

 

ICPT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.